First batch recall for therapeutic cannabis trials
Just over a week after the launch of medical cannabis trials, This first batch recall follows a number of incidents reported to the French National Agency for the Safety of Medicines (ANSM).
According to our information, the product in question, distributed by French laboratory Medipha, is the oral solution (10% THC / 10% CBD) from Canadian producer Tilray, a full-spectrum oil containing 10 mg/mL THC and 10 mg/mL CBD, which is said to be leaking from the bottle cap.
The recall will take place shortly, and the drug can no longer be prescribed for the time being. To avoid any further delay in the start of the trial, the batch's secondary supplier - Australian cannabis producer Little Green Pharma in partnership with French pharmaceutical company Intsel Chimos - is set to take over.
The same product had already suffered recalls as part of Germany's medical cannabis program, this time due to too low a THC content compared to what was labeled.
When contacted, Tilray did not respond to our request.
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
Organigram Enters the Race for Aurora Cannabis
Medical Cannabis: Augur Associates’ latest report provides an update ahead of the publication of the decrees
Golden Buds is relaunching its Nova High vape pens with a cannabinoid formula that’s out of the ordinary
Cannabis is now Canada's fifth-largest commercial crop
Bedrocan Finally Declared Bankrupt
After CBD, Can Wellness Exist Without Cannabinoids?
Uganda Launches a Cooperative Dedicated to Medical Cannabis
Ukraine: First Cancer Patient Prescribed Medical Cannabis
Cannabis Oil and Endometriosis: A Promising Study for Pain Relief
-
Business1 week agoThe legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks agoWhich countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the Netherlands4 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
You must be logged in to post a comment Login